AL Amyloidosis (Primary Amyloidosis): Symptoms, Treatment & What it Is
Immunoglossary
Immunoglobulin Light Chain - an overview | ScienceDirect Topics
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - The FEBS Journal - Wiley Online Library
23.3. Antibodies – Concepts of Biology – 1st Canadian Edition
Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation? - ScienceDirect
JCM | Free Full-Text | Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis | JACC: Basic to Translational Science
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Immune system - Classes of immunoglobulins | Britannica
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Immune system - Labpedia.net
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
Update on treatment of light chain amyloidosis | Haematologica
![Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8771/1/fig-4-2x.jpg "Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]")
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
Immunoglobulin Mu Chain - an overview | ScienceDirect Topics
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
Light chain amyloidosis pathology. Clonal expansion of plasma cells... | Download Scientific Diagram
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Frontiers | Comparative Aspects of Immunoglobulin Gene Rearrangement Arrays in Different Species
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation | eLife
